SEC Form 4 · accession 0000921895-17-001062
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur M Langer
Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 14, 2017 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 64,870 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Apr 11, 2017 | A | 7,680 | A | — | — | Common Stock | 7,680 | 7,680 | D |
| Restricted Stock UnitF1,F3 | — | Apr 11, 2017 | A | 7,680 | A | — | — | Common Stock | 7,680 | 7,680 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
- F2These Restricted Stock Units are scheduled to vest on May 1, 2017.
- F3These Restricted Stock Units are scheduled to vest on January 1, 2018.